06:54 AM EDT, 05/01/2024 (MT Newswires) -- GSK (GSK) reported Q1 core earnings Wednesday of 0.431 British pounds ($0.54) per share, up from 0.37 pounds a year earlier.

Analysts polled by Capital IQ expected 0.37 pounds.

Turnover for the quarter ended March 31 was 7.36 billion pounds, up from 6.95 billion pounds a year earlier.

Analysts surveyed by Capital IQ expected 7.06 billion pounds.

For 2024, the UK-based pharmaceutical company lifted its earnings per share growth forecast to 8% to 10%, from the previous 6% to 9%, on turnover growth upgraded toward the upper part of the previously projected 5% to 7%. Analysts polled by Capital IQ expect earnings of 1.58 pounds on revenue of 31.48 billion pounds.

Shares of the company were up nearly 3% in recent Wednesday premarket activity.

Price: 42.54, Change: +1.10, Percent Change: +2.65